Treatment of PPMS with OCR is more cost effective from a societal than a healthcare perspective, therefore prioritisation of public funding of novel pharmaceuticals for MS and other resource intensive chronic health conditions will depend critically upon the study perspective.

Discrete choice experiments (DCEs) provide a method for understanding preferences for service provision and there have been limited applications to the selection of community pharmacies. The validity and accuracy of DCEs rely upon the attributes and levels used. This paper aims to describe the development of a DCE investigating New Zealanders preferences for community pharmacies.

Exploring lived experience provides insights into the multiple ways that lack of affordability prevents access to medicines: directly, through interaction with other barriers to access including transport, by damaging trust and reducing acceptability of services, and by making participants less able to deal with mistakes made by health professionals.